Sh2,500.00
Azithromycin 500mg (sold under the brand name Azicure) is an antibiotic medication used to treat bacterial infections in different parts of the body
Here are some of the specific uses of Azithromycin 500mg (Zadiways):
| Settings | AZITHROMYCIN 500MG ZADIWAYS 3S remove | Aciclovir 200mg Tablets remove | Acetazolamide Tablets 250mg remove | Ascard 75 Tablets remove | AMBROX DROPS 15ML remove | Artequick Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh2,500.00 | Sh15,000.00 | Sh20,000.00 | Sh3,000.00 | Sh2,500.00 | Sh11,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | Azithromycin 500mg (sold under the brand name Azicure) is an antibiotic medication used to treat bacterial infections in different parts of the body |
|
| Ambroxol drops are a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | ||
| Content |
Here are some of the specific uses of Azithromycin 500mg (Zadiways):
| Aciclovir 200 mg Tablets contain a medicine called aciclovir. This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses. | Acetazolamide 250mg Tablets contain the active substance Acetazolamide. This belongs to a group of medicines known as carbonic anhydrase inhibitors. | Ascard belongs to the category of Anti-platelet and Anti-coagulant drugs. It prevents blood clots and helps the blood in flowing smoothly. It is primarily used for the prevention of cardiovascular diseases and to relieve muscle aches, toothaches, and headaches. | The main uses of Ambroxol drops include:
| Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.